ST2 is a unique IL-33 receptor, and appropriate inhibition of IL-33/ST2 reduces the immunopathology of schistosomes; however, knockdown of IL-33 or ST2 exacerbates schistosomiasis liver pathology (Li et al., 2019; Bai et al., 2021). The gene discussed is IL33; the disease is schistosomiasis.